Mechanisms Regulating Cytokine Release from Peritoneal Macrophages during Continuous Ambulatory Peritoneal Dialysis

Blood Purification

Volumn 14, Issue 2, 1996, Pages 179-187

  Fieren, Marien W J A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Continuous ambulatory; Infection; Interleukin 1; Macrophages; Nitric oxide; Peritoneal dialysis; Prostacyclin; Prostaglandin E2; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; PROSTANOID; TUMOR NECROSIS FACTOR ALPHA;

CELL STIMULATION; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFECTION; LYMPHOCYTE; MESOTHELIUM CELL; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PERITONITIS; PRIORITY JOURNAL;

ANIMALS; DINOPROSTONE; INTERLEUKIN-1; MACROPHAGES, PERITONEAL; MICE; MODELS, BIOLOGICAL; NITRIC OXIDE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029875730     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000170261     Document Type: Article

References (60)

1. Adams DO. Hamilton TA: Macrophages as destructive cells in host defence; in Gallin JI. Goldstein IM. Snydcrmond R (eds): Inflammation. Basic Principles and Clinical Correlates. ed 2. New York. Raven Press. 1992. pp 637-662.
2. Maddox Y. Foegh M, Zcligs B. Zrnudka M. Bellanti J, Ramwell P: A routine source of human peritoneal macrophages. Scand J Immunol 1984;19:23-29.
3. Bonta IL. Adolfs MJP. Fiercn M WJA: Cyclic AMP levels and their regulation by prostaglandins in peritoneal macrophages of rats and humans. Int J Immunopharmacol 1984;6:547-555.
4. Goldstein CS. Bomalaski JS. Zurier RB. Neilson EG. Douglas SD: Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Kidney Int 1984: 26:733-740.
5. Dinarello CA: Role of interleukin-1 and tumor necrosis factor in systemic responses to infection and inflammation; in Gallin JI. Goldstein IM. Snyderman R (eds): Inflammation. Basic Principles and Clinical Correlates, ed 2. New York, Raven Press. 1992. pp 211-232.
6. Bonta IL, Ben-Efraim S, Mozes T, Fieren MWJA: Tumour necrosis factor in inflammation: Relation to other mediators and to macrophage antitumour defence. Pharmacol Res 1991:24:115-130.
7. Shaldon S, Koch KM, Quelhorst E, Dinarello CA: Pathogenesis of sclerosing peritonitis in CAPD. Trans Am Soc Artif Intern Organs 1984: 30:193-194.
8. Fieren MWJA. van den Bemd GJCM. Bonta IL: Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1β in vitro during infectious peritonitis. Eur J Clin Invest 1990: 20:453-457.
9. Fieren MWJA, van den Bemd GJCM. Bonta IL., Ben-Efraim S: Peritoneal macrophages from patients oil continuous ambulatory peritoneal dialysis have an increased capability to release tumor necrosis factor during peritonitis. J Clin Lab Immunol 1991:34:1-9.
10. Gordon S, Unkeless JC, Cohn ZA: Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis. J Exp Med 1974:140:995-1010.
11. Bonta IL. Ben-Efraim S: Involvement of inflammatory mediators in macrophage antitumor activity. J Leukoc Biol 1993;54:613-626.
12. Ben-Efraim S, Tak C, Fieren MWJA, van den Bemd GJ, Bonta IL: Inflammation amplifies the antitumor evtostasis by human peritoneal macrophages. Med Oncol Tumor Pharmacothcr 1991:8:87-94.
13. Ben-Efraim S, Tak C, Fieren MWJA, Romijn JC, Beckmann J, Bonta IL: Activity of human peritoneal macrophages against a human tumor: Role of tumor necrosis factor-u and nitrite in vitro studies. Immunol Lett 1993;37:27-33.
14. Ben-Efraim S. Tak C. Romijn JC. Fieren MWJA. Bonta IL: Therapeutical effect of activated human macrophages on a human tumor line growing in nude mice. Med Oncol 1993;11:7-12.
15. Thomberry NA. Bull HG. Calaycay JR. Chapman KT. Howard AD. Kostura MA. Miller DK. Molineaux SM. Wcidner JR. Aunins J. Elliston KO, Ayala JM, Casano FJ. Chin J. Ding GJF. Eggcr LA. Gaffney EP. Limjuco G. Palyha OC. Raju SM, Rolando AM. Salley JP. Yamin TT. Lee TD. Shively JE, MacCross M, Mumford RA. Schmidt JA, Tocci MJ: A novel hctcrodimeric cysteine protease is required for intcrleukin-1β processing in monocytes. Nature 1992:356:768-774.
16. Hazuda DJ, Lee JC, Young PR: The kinetics of interleukin-1 secretion from activated monocytes. J Biol Chcm 1988:263:8473-8479.
17. Hogquisl KA, Nett MA, Unanuc ER. Chaplin DD: Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci 1991:88: 8485-8489.
18. Herzyk DJ. Berger AE. Allen JN. Wcwcrs MD: Sandwich ELISA formats designed to detect 17 kDA 1L-lp significantly underestimate 35 kDa IL-1β. J Immunol Methods 1992:148:248-254.
19. Chin J, Kostura MJ: Dissociation of IL-1β synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products. J Immunol 1993:151:5574-5585.
20. Munoz C, Carlct J, Fitting C, Misset B, Bleriot JP, Cavaillon JM: Dysreg-ulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991:88:1747-1754.
21. Knopf HP. Otto F, Engelhardt R. Freudenberg MA. Galanos C, Herrmann F. Schumann RR: Discordant adaptation of human peritoneal macrophages to stimulation by lipo-polysaccharide and the synthetic lipid A analogue SDZ MRL 953. J Immunol 1994:153:287-299.
22. Spatafora M, Mcrendino FCCPA, Chiappara G, Gjomarkaj M, Bon-signore G: Lung compartmentaliza-tion of increased TNF releasing ability by mononuclear phagocytes in pulmonary sarcoidosis. Chest 1989; 96:542-549.
23. Friedlander MA, Hilbert CM, Wu YC, Rich EA: Role of dialysis modality in responses of blood monocytes and peritoneal macrophages to endotoxin stimulation. Am J Kidney Dis 1993;22:11-23.
24. Wewers MD. Herzyk DJ: Alveolar macrophages differ from blood monocytes in human IL-lp release. J Immunol 1989;143:1635-1641.
25. Adolfs MJP. Fieren MWJA. Bonta IL: Infectious-inflammatory changes in cyclic AMP levels and in their regulation by prostaglandins in human peritoneal macrophages. Prostaglandins Leukot Med 1985:18: 217-226.
26. Fieren MWJA, Adolfs MJP, Bonta IL: Alterations in sensitivity and Se-cretion of prostaglandins of human macrophages during CAPD-related peritonitis. Contrib Nephrol 1987; 57:55-62.
27. Fieren MWJA, vd Bemd GJCM, Bonta IL: Peritoneal macrophages from patients on continuous ambulatory' peritoneal dialysis show a differential secretion of prostanoids and interleukin-1β. Prostaglandins Leukot Essent Fatty Acids 1992:47: 23-28.
28. Humes JL, Burger S, Galavage M, Kuehl FA, Wightman PD, Dahlgren ME, Davies P, Bonney RJ: The diminished production of arachidonic acid oxygenation products by elictcd mouse peritoneal macrophages. Possible mechanisms. J Immunol 1990: 124:2110-2116.
29. Mackenzie RK, Coles GA, Williams JD: Eicosanoid synthesis in human peritoneal macrophages stimulated with S. epidermidis. Kidney Int 1990:37:1316-1324.
30. Mackenzie RK. Coles GA. Williams JD: The response of human peritoneal macrophages to stimulation with bacteria isolated from episodes of continuous ambulatory peritoneal dialvsis-rclatcd peritonitis. J Infect D is 1991:163:837-842.
31. Mackenzie R, Coles GA, Topley N, Powell WS, Williams JD: Down-regulation of cyclooxygenase product generation by human peritoneal macrophages. Immunology 1992; 76:648-654.
32. Stcinhauer HB, Gunther B, Schollmeyer P: Stimulation of peritoneal synthesis of vasoactive prostaglandins during peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Invest 1985:15: 1-5
33. Topley N. Petersen MM. Mackenzie R. Ncubauer A, Stylianou E, Kacvcr V. Davies M. Coles GA. Jorres A. Williams JD: Human peritoneal mesothelial cell prostaglandin synthesis: Induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. Kidney Int 1994: 46:900-909.
34. Bonta IL. Parnham MJ: Immunomodulatory-antiinflammatory functions of E-type prostaglandins. Min-ireview with emphasis on macrophage-mediated effects. Int J Immu-nopharmacol 1982:4:103-109.
35. Fieren MWJA, van den Bemd GJCM, Ben-Efraim S, Bonta IL: Prostaglandin E; inhibits the release of tumor necrosis factor-α, rather than interleukin-1β. from human macrophages. Immunol Lett 1991: 31:85-90.
36. 2. Biochem Biophys Res Commun 1986:137: 404-410.
37. 2-mediated suppression of lipopolvsac-charidc-induccd tumor necrosis factor alpha gene expression. Infect Immun 1989:57:2837-2841.
38. Knudsen PJ. Dinarello CA. Strom TB: Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin-1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 1986:137:3189-3194.
39. Kunkel SL. Chensue SW. Phan SH: Prostaglandins as endogenous mediators of interleukin I production. J Immunol 1986:136:186-192.
40. Scales WE. Chensue SW. Ottcrncss I. Kunkel SL: Regulation of monokine gene expression: Prostaglandin Et suppresses tumor necrosis factor but not interleukin-1 α or β-mRNA and cell-associated bioactivity. J Leukoc Biol 1989:45:416-421.
41. Endrws S, Ftille HJ, Sinha B, Stoll D, Dinarello CA, Gerzer R, Weber PC: Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-u and interleukin-Ip by human mononuclear cells. Immunology 1991;72:56-60.
42. Viherluoto J. Palkama T. Silvcn-noinen O. Hurme M: Cyclic adenosine monophosphate decreases the secretion, but not the cell-associated levels, of interleukin-lp in lipopoly-saccharidc-activatcd human monocytes. Scand J Immunol 1991:34: 121-125.
43. Serkkola E, Hurme M, Palkama T: Prolonged elevation of intracellular cyclic AMP activates intcrlcukin-1 production in human peripheral blood monocytes. Scand J Immunol 1992;35:203-208.
44. Molnar-Kimber KL, Yonno L, Heaslip RJ, Weichman BM: Differential regulation of TNF-a and 1L-ip production from endotoxin stimulated human monocytes by phosphodiesterase inhibitors. Med Inflamm 1992;1:411-417.
45. van Dcuren M, van de Ven-Jongekrijg J, Demacker PNM, Bartclink AKM, van Dalen R, Sauerwein RW, Gallati H, Vannicc JL, van de Meer JWM: Differential expression of proinflammatory cytokines and their inhibitor during the course of meningococcal infections. J Infect Dis 1994;169:157-161.
46. Dasgupta MK. Larabic M. Halloran F: Interferon-gamma levels in peritoneal dialysis effluents: Relation to peritonitis. Kidney Int 1994:46: 475-481.
47. Hart PH. Cooper RL. Finlav-Joncs JJ: IL-4 suppresses IL-1β. TNF-α and PGE; production by human peritoneal macrophages. Immunology 1991:72:344-349.
48. De Waal Malelyt R. Abrams J. Bennett B. Figdor CG. de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autorcgulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
49. Dinarello CA: Interleukin-1 and in-terleukin-l antagonism. Blood 1991:77:1627-1652.
50. Engelmann H, Novick D, Wallach D: Two tumor necrosis factor-binding proteins purified from human urine. J Biol Chem 1990:265:1531-1536.
51. Topley N. Jorres A, Luttmann W. Petersen MM. Lang MJ. Thicraueh KH. Coles GA. Davies M, Williams JD: Human peritoneal mesothelial cells synthesize intcrleukin-6: Induction by IL-1β and TNFα. Kidney Int 1993:43:226-233.
52. Zemel D, Krediet RT, Koomen GCM, Kortekaas WMR, Geertzen HGM, ten Berge RJM: Intcrleukin-8 during peritonitis in patients treated with CAPD: an in-vivo model of acute inflammation. Nephrol Dial Transplant 1994:9:169-174.
53. Denis M: Human monocytcs/macrophages: NO or no NO? J Leukoc Biol 1994:55:682-684.
54. Schneemann M. Schoedon G. Hofcr S. Blau N. Guerrero L. Schaffncr A: Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes.J Infect Dis 1993:167:1358-1363.
55. Topley N, Brown Z. Jorrcs A. Wcst-wick J, Davies M. Coles GA, Williams JD: Human peritoneal meso-thclial cells synthesize interleukin-8. Am J Pathol 1992; 142:1876-1886.
56. Brauncr A, Hylander B, Wretlind B: lnterleukin-6 and intcrleukin-8 in dialysatc and serum from patients on continuous ambulatory dialysis. Am J Kidney Dis 1993:22:430-435.
57. Zemel D, Koomen GC. Hart AAM, ten Berge IJM. Struijk DG. Krediet RT: Relationship of TNF-α. Interleukin-6. and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993:122:686-696.
58. Cameron ML, Granger DL, Weinberg JB, Kozumbo WJ, Koren HS: Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Rcspir Dis 1990:142:1313-1319.
59. Dumarey CH, Labrouss V, Rastogi N, Vargaftig BB, Bachelet M: Selective Mycobacterium avium-in-duced production of nitric oxide by human monocyte-derived macrophages.J Leukoc Biol 1994:56:36-40.
60. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Slcath PR, Salvesen GS, Pickup PJ: Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interlcukin-1β converting enzyme. Cell 1992:69: 597-604.